Latest news
The Japanese Cancer Association and Debiopharm Group Announce Winners of the 2015 JCA-Mauvernay Award
Debiopharm Group™ inaugure son site de production et son laboratoire de recherche après 18 mois de travaux, à Martigny.
Debiopharm International SA and Solid Biosciences, LLC, announce a collaboration to explore the use of Alisporivir (Debio 025) in muscular…
Debiopharm International SA acquires FibroTrap sample processing technology from Spinomix
Debiopharm International SA Announces Phase III Positive Results for Triptorelin 6-month Formulation in the Management of Central Precocious Puberty (CPP)
Debiopharm International SA initiates clinical phase II study evaluating Debio 1450 in Staphylococcal skin infections
Debiopharm International SA announces results of 2 key oncology programs at 2015 AACR Conference
Debiopharm Diagnostics leads investment round in GenePOC with Emerillon Capital